Allurion Technologies (ALUR) Total Non-Current Liabilities (2022 - 2026)
Allurion Technologies (ALUR) posted Total Non-Current Liabilities of $86.8 million for Q1 2026, down 6.23% on a QoQ basis from $92.6 million in Q4 2025, and down 12.26% year-over-year from $98.9 million in Q1 2025.
Allurion Technologies (ALUR) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends
Allurion Technologies' Total Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $86.8 million for Q1 2026.
- Quarterly Total Non-Current Liabilities fell 12.26% year-over-year to $86.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $86.8 million (down 12.26% YoY) and the FY2025 annual result came in at $92.6 million, down 16.43% from the prior year.
- Total Non-Current Liabilities was $86.8 million for Q1 2026 at Allurion Technologies, down from $92.6 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $161.4 million in Q3 2023 and bottomed at -$400000.0 in Q3 2022.
- A 5-year average of $100.2 million and a median of $102.4 million in 2024 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Non-Current Liabilities soared 40456.5% — and 2024, when it tumbled 35.18%.
- Allurion Technologies' Total Non-Current Liabilities stood at $81.1 million in 2022, then surged by 66.01% to $134.7 million in 2023, then dropped by 17.75% to $110.8 million in 2024, then fell by 16.43% to $92.6 million in 2025, then retreated by 6.23% to $86.8 million in 2026.
- Business Quant data shows ALUR's Total Non-Current Liabilities at $86.8 million in Q1 2026, $92.6 million in Q4 2025, and $100.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | 86.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86.81 Mn |
| Dec 31, 2025 | 92.58 Mn |
| Sep 30, 2025 | 100.25 Mn |
| Jun 30, 2025 | 91.22 Mn |
| Mar 31, 2025 | 98.94 Mn |
| Dec 31, 2024 | 110.77 Mn |
| Sep 30, 2024 | 104.64 Mn |
| Jun 30, 2024 | 111.52 Mn |
| Mar 31, 2024 | 116.35 Mn |
| Dec 31, 2023 | 134.69 Mn |
| Sep 30, 2023 | 161.43 Mn |
| Jun 30, 2023 | 112.49 Mn |
| Dec 31, 2022 | 81.13 Mn |
| Sep 30, 2022 | -400,000.00 |